{
  "DOI": "10.1007/s10689-024-00363-6",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-024-00363-6",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eScreening of the general population for cancer is a matter of primary prevention reducing the burden of disease. Whilst this is successful for several cancers including breast, colon and prostate, the situation to screen and hence prevent pancreatic cancer is different. The organ is not as accessible to simple physical exam or biological samples (fecal or blood test). Neither exists a blood test such as PSA that is cost-effective. Reviewing the evidence from screening risk groups for pancreatic cancer, one must conclude that there is no rational at present to screen the general population, for a lack of appropriate tests.\u003c/jats:p\u003e",
  "alternative-id": [
    "363"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "2 December 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "5 February 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "5 March 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Löhr",
      "given": "J.-Matthias",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Öhlund",
      "given": "Daniel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Söreskog",
      "given": "Emma",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Andersson",
      "given": "Emil",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vujasinovic",
      "given": "Miroslav",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zethraeus",
      "given": "Niklas",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sund",
      "given": "Malin",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        3,
        5
      ]
    ],
    "date-time": "2024-03-05T08:02:02Z",
    "timestamp": 1709625722000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        3,
        5
      ]
    ],
    "date-time": "2024-03-05T08:14:30Z",
    "timestamp": 1709626470000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004047",
      "doi-asserted-by": "crossref",
      "name": "Karolinska Institute"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        6
      ]
    ],
    "date-time": "2024-03-06T00:38:03Z",
    "timestamp": 1709685483721
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2024,
        3,
        5
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            3,
            5
          ]
        ],
        "date-time": "2024-03-05T00:00:00Z",
        "timestamp": 1709596800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            3,
            5
          ]
        ],
        "date-time": "2024-03-05T00:00:00Z",
        "timestamp": 1709596800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-024-00363-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-024-00363-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-024-00363-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2024,
        3,
        5
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        3,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1136/gutjnl-2019-319352",
      "author": "M Goggins",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "Gut",
      "key": "363_CR1",
      "unstructured": "Goggins M, Overbeek KA, Brand R et al (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the pancreas Screening (CAPS) Consortium. Gut 69:7–17",
      "volume": "69",
      "year": "2020"
    },
    {
      "DOI": "10.3390/jcm9113720",
      "doi-asserted-by": "crossref",
      "key": "363_CR2",
      "unstructured": "Vujasinovic M, Dugic A, Maisonneuve P et al (2020) Risk of developing pancreatic Cancer in patients with chronic pancreatitis. J Clin Med ;9"
    },
    {
      "DOI": "10.1159/000455963",
      "author": "A Schneider",
      "doi-asserted-by": "publisher",
      "first-page": "172",
      "journal-title": "Digestion",
      "key": "363_CR3",
      "unstructured": "Schneider A, Hirth M, Munch M et al (2017) Risk of Cancer in patients with autoimmune pancreatitis: a single-center experience from Germany. Digestion 95:172–180",
      "volume": "95",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00330-022-08650-5",
      "author": "RM Pozzi Mucelli",
      "doi-asserted-by": "publisher",
      "first-page": "5144",
      "journal-title": "Eur Radiol",
      "key": "363_CR4",
      "unstructured": "Pozzi Mucelli RM, Moro CF, Del Chiaro M et al (2022) Branch-duct intraductal papillary mucinous neoplasm (IPMN): are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria? Eur Radiol 32:5144–5155",
      "volume": "32",
      "year": "2022"
    },
    {
      "DOI": "10.1001/jamasurg.2014.3852",
      "author": "M Del Chiaro",
      "doi-asserted-by": "publisher",
      "first-page": "512",
      "journal-title": "JAMA Surg",
      "key": "363_CR5",
      "unstructured": "Del Chiaro M, Verbeke CS, Kartalis N et al (2015) Short-term results of a magnetic resonance imaging-based Swedish screening program for individuals at risk for pancreatic Cancer. JAMA Surg 150:512–518",
      "volume": "150",
      "year": "2015"
    },
    {
      "DOI": "10.1053/j.gastro.2018.05.035",
      "doi-asserted-by": "crossref",
      "key": "363_CR6",
      "unstructured": "Canto MI, Almario JA, Schulick RD et al (2018) Risk of neoplastic progression in individuals at high risk for pancreatic Cancer Undergoing Long-Term Surveillance. Gastroenterology"
    },
    {
      "DOI": "10.1053/j.gastro.2012.01.005",
      "author": "MI Canto",
      "doi-asserted-by": "publisher",
      "first-page": "796",
      "journal-title": "Gastroenterology",
      "key": "363_CR7",
      "unstructured": "Canto MI, Hruban RH, Fishman EK et al (2012) Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142:796–804 quiz e14-5",
      "volume": "142",
      "year": "2012"
    },
    {
      "key": "363_CR8",
      "unstructured": "Paiella S, Capurso G, Carrara S et al (2023) Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer. Am J Gastroenterol"
    },
    {
      "DOI": "10.1053/j.gastro.2021.10.014",
      "author": "KA Overbeek",
      "doi-asserted-by": "publisher",
      "first-page": "772",
      "journal-title": "Gastroenterology",
      "key": "363_CR9",
      "unstructured": "Overbeek KA, Goggins MG, Dbouk M et al (2022) Timeline of Development of Pancreatic Cancer and implications for successful early detection in high-risk individuals. Gastroenterology 162:772–785e4",
      "volume": "162",
      "year": "2022"
    },
    {
      "DOI": "10.1053/j.gastro.2005.05.012",
      "author": "DJ Robertson",
      "doi-asserted-by": "publisher",
      "first-page": "34",
      "journal-title": "Gastroenterology",
      "key": "363_CR10",
      "unstructured": "Robertson DJ, Greenberg ER, Beach M et al (2005) Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129:34–41",
      "volume": "129",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s12029-022-00821-3",
      "author": "D Hernandez",
      "doi-asserted-by": "publisher",
      "first-page": "391",
      "journal-title": "J Gastrointest Cancer",
      "key": "363_CR11",
      "unstructured": "Hernandez D, Wagner F, Hernandez-Villafuerte K, Schlander M (2023) Economic Burden of Pancreatic Cancer in Europe: a literature review. J Gastrointest Cancer 54:391–407",
      "volume": "54",
      "year": "2023"
    },
    {
      "DOI": "10.1097/MPA.0000000000001268",
      "doi-asserted-by": "crossref",
      "key": "363_CR12",
      "unstructured": "Corral JE, Das A, Bruno MJ, Wallace MB (2019) Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis. Pancreas. ;48:526–536"
    },
    {
      "DOI": "10.1016/j.cgh.2018.04.065",
      "author": "JE Corral",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "Clin Gastroenterol Hepatol",
      "key": "363_CR13",
      "unstructured": "Corral JE, Mareth KF, Riegert-Johnson DL et al (2019) Diagnostic yield from screening asymptomatic individuals at high risk for pancreatic Cancer: a Meta-analysis of Cohort studies. Clin Gastroenterol Hepatol 17:41–53",
      "volume": "17",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.bpg.2021.101783",
      "doi-asserted-by": "crossref",
      "key": "363_CR14",
      "unstructured": "Klatte DCF, Wallace MB, Löhr M et al (2022) Hereditary pancreatic cancer. Best Pract Res Clin Gastroenterol :101783"
    },
    {
      "DOI": "10.1053/j.gastro.2020.03.088",
      "author": "HR Aslanian",
      "doi-asserted-by": "publisher",
      "first-page": "358",
      "journal-title": "Gastroenterology",
      "key": "363_CR15",
      "unstructured": "Aslanian HR, Lee JH, Canto MI (2020) AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology 159:358–362",
      "volume": "159",
      "year": "2020"
    },
    {
      "DOI": "10.1136/gutjnl-2016-313127",
      "author": "ML Kromrey",
      "doi-asserted-by": "publisher",
      "first-page": "138",
      "journal-title": "Gut",
      "key": "363_CR16",
      "unstructured": "Kromrey ML, Bulow R, Hubner J et al (2018) Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 67:138–145",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1136/gutjnl-2012-303006",
      "author": "DS Michaud",
      "doi-asserted-by": "publisher",
      "first-page": "1764",
      "journal-title": "Gut",
      "key": "363_CR17",
      "unstructured": "Michaud DS, Izard J, Wilhelm-Benartzi CS et al (2013) Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 62:1764–1770",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.3390/ijms232112969",
      "doi-asserted-by": "crossref",
      "key": "363_CR18",
      "unstructured": "Mason J, Lundberg E, Jonsson P et al (2022) A cross-sectional and longitudinal analysis of pre-diagnostic blood plasma biomarkers for early detection of pancreatic Cancer. Int J Mol Sci ;23"
    },
    {
      "DOI": "10.1200/JCO.2017.77.6658",
      "author": "LD Mellby",
      "doi-asserted-by": "publisher",
      "first-page": "2887",
      "journal-title": "J Clin Oncol",
      "key": "363_CR19",
      "unstructured": "Mellby LD, Nyberg AP, Johansen JS et al (2018) Serum biomarker signature-based Liquid Biopsy for diagnosis of early-stage pancreatic Cancer. J Clin Oncol 36:2887–2894",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.21203/rs.3.rs-76139/v1",
      "doi-asserted-by": "crossref",
      "key": "363_CR20",
      "unstructured": "Jacobson S, Dahlqvist P, Johansson M et al (2021) Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels. Pancreatology"
    },
    {
      "DOI": "10.3390/cancers13215321",
      "doi-asserted-by": "crossref",
      "key": "363_CR21",
      "unstructured": "Borgmastars E, Lundberg E, Ohlund D et al (2021) Circulating tissue polypeptide-specific Antigen in Pre-diagnostic Pancreatic Cancer samples. Cancers (Basel) ;13"
    },
    {
      "DOI": "10.1097/SLA.0000000000002124",
      "author": "O Franklin",
      "doi-asserted-by": "publisher",
      "first-page": "775",
      "journal-title": "Ann Surg",
      "key": "363_CR22",
      "unstructured": "Franklin O, Jonsson P, Billing O et al (2018) Plasma Micro-RNA alterations appear late in pancreatic Cancer. Ann Surg 267:775–781",
      "volume": "267",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ueg2.12422",
      "author": "IJM Levink",
      "doi-asserted-by": "publisher",
      "first-page": "601",
      "journal-title": "United Eur Gastroenterol J",
      "key": "363_CR23",
      "unstructured": "Levink IJM, Jaarsma SC, Koopmann BDM et al (2023) The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program. United Eur Gastroenterol J 11:601–611",
      "volume": "11",
      "year": "2023"
    },
    {
      "DOI": "10.14309/ajg.0000000000002022",
      "author": "R Santos",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "journal-title": "Am J Gastroenterol",
      "key": "363_CR24",
      "unstructured": "Santos R, Coleman HG, Cairnduff V, Kunzmann AT (2023) Clinical prediction models for pancreatic Cancer in General and At-Risk populations: a systematic review. Am J Gastroenterol 118:26–40",
      "volume": "118",
      "year": "2023"
    },
    {
      "DOI": "10.1136/bmj.g5261",
      "author": "JM Löhr",
      "doi-asserted-by": "publisher",
      "first-page": "g5261",
      "journal-title": "BMJ",
      "key": "363_CR25",
      "unstructured": "Löhr JM (2014) Personal view: pancreatic cancer should be treated as a medical emergency. BMJ 349:g5261",
      "volume": "349",
      "year": "2014"
    },
    {
      "DOI": "10.1053/j.gastro.2019.01.039",
      "author": "RP Sah",
      "doi-asserted-by": "publisher",
      "first-page": "1742",
      "journal-title": "Gastroenterology",
      "key": "363_CR26",
      "unstructured": "Sah RP, Sharma A, Nagpal S et al (2019) Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma. Gastroenterology 156:1742–1752",
      "volume": "156",
      "year": "2019"
    },
    {
      "key": "363_CR27",
      "unstructured": "Huang BZ, Pandol SJ, Jeon CY et al (2019) New-Onset Diabetes, Longitudinal trends in metabolic markers, and risk of pancreatic Cancer in a Heterogeneous Population. Clin Gastroenterol Hepatol"
    },
    {
      "DOI": "10.6004/jnccn.2020.7798",
      "author": "NRM Schwartz",
      "doi-asserted-by": "publisher",
      "first-page": "451",
      "journal-title": "J Natl Compr Canc Netw",
      "key": "363_CR28",
      "unstructured": "Schwartz NRM, Matrisian LM, Shrader EE et al (2021) Potential cost-effectiveness of risk-based pancreatic Cancer screening in patients with New-Onset diabetes. J Natl Compr Canc Netw 20:451–459",
      "volume": "20",
      "year": "2021"
    },
    {
      "DOI": "10.3390/cancers15194876",
      "doi-asserted-by": "crossref",
      "key": "363_CR29",
      "unstructured": "Lipp M, Tarjan D, Lee J et al (2023) Fatty pancreas is a risk factor for pancreatic Cancer: a systematic review and Meta-analysis of 2956 patients. Cancers (Basel) ;15"
    },
    {
      "DOI": "10.1007/s00330-022-08922-0",
      "author": "Y Gao",
      "doi-asserted-by": "publisher",
      "first-page": "8443",
      "journal-title": "Eur Radiol",
      "key": "363_CR30",
      "unstructured": "Gao Y, Cheng S, Zhu L et al (2022) A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks? Eur Radiol 32:8443–8452",
      "volume": "32",
      "year": "2022"
    },
    {
      "DOI": "10.1053/j.gastro.2023.04.003",
      "author": "M Schuurmans",
      "doi-asserted-by": "publisher",
      "first-page": "309",
      "journal-title": "Gastroenterology",
      "key": "363_CR31",
      "unstructured": "Schuurmans M, Alves N, Vendittelli P et al (2023) Artificial Intelligence in Pancreatic Ductal Adenocarcinoma Imaging: a commentary on potential future applications. Gastroenterology 165:309–316",
      "volume": "165",
      "year": "2023"
    },
    {
      "DOI": "10.1186/s12943-023-01870-3",
      "author": "K Wang",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "journal-title": "Mol Cancer",
      "key": "363_CR32",
      "unstructured": "Wang K, Wang X, Pan Q, Zhao B (2023) Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation. Mol Cancer 22:167",
      "volume": "22",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41571-023-00781-y",
      "author": "R Lawrence",
      "doi-asserted-by": "publisher",
      "first-page": "487",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "363_CR33",
      "unstructured": "Lawrence R, Watters M, Davies CR et al (2023) Circulating tumour cells for early detection of clinically relevant cancer. Nat Rev Clin Oncol 20:487–500",
      "volume": "20",
      "year": "2023"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-024-00363-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy"
}